Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.

Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD; INSIGHT SMART Group.

AIDS. 2011 Mar 13;25(5):651-7. doi: 10.1097/QAD.0b013e32834404a1.

2.

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N.

Eur Heart J. 2013 Feb;34(6):443-50. doi: 10.1093/eurheartj/ehs239. Epub 2012 Aug 31. Erratum in: Eur Heart J. 2013 Apr;34(15):1094.

3.

N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.

Berg T, Zdunek D, Stalke J, Dupke S, Baumgarten A, Carganico A, Hess G.

Eur J Med Res. 2007 Apr 26;12(4):152-60.

PMID:
17509959
4.
5.

Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.

Dirajlal-Fargo S, Kinley B, Jiang Y, Longenecker CT, Hileman CO, Debanne S, McComsey GA.

AIDS. 2015 Jan 28;29(3):313-21. doi: 10.1097/QAD.0000000000000547.

6.

NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.

Kara K, Lehmann N, Neumann T, Kälsch H, Möhlenkamp S, Dykun I, Broecker-Preuss M, Pundt N, Moebus S, Jöckel KH, Erbel R, Mahabadi AA.

Int J Cardiol. 2015 Mar 15;183:155-61. doi: 10.1016/j.ijcard.2015.01.082. Epub 2015 Jan 29.

PMID:
25666125
7.

N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.

Bruno G, Landi A, Barutta F, Ghezzo G, Baldin C, Spadafora L, Schimmenti A, Prinzis T, Cavallo Perin P, Gruden G.

Diabetes Care. 2013 Sep;36(9):2677-82. doi: 10.2337/dc13-0353. Epub 2013 Apr 5.

8.

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.

West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; LIPID Study Investigators.

Eur Heart J. 2008 Apr;29(7):923-31. doi: 10.1093/eurheartj/ehn007. Epub 2008 Feb 22.

PMID:
18296678
9.

Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.

Karakas M, Jaensch A, Breitling LP, Brenner H, Koenig W, Rothenbacher D.

Clin Chem. 2014 Nov;60(11):1441-9. doi: 10.1373/clinchem.2013.220202. Epub 2014 Aug 19.

10.

N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.

Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, Rumley A, Whincup PH, Sattar N.

J Am Coll Cardiol. 2011 Jun 28;58(1):56-64. doi: 10.1016/j.jacc.2011.02.041.

11.

Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).

Everett BM, Ridker PM, Cook NR, Pradhan AD.

Am J Cardiol. 2015 Aug 15;116(4):532-7. doi: 10.1016/j.amjcard.2015.05.014. Epub 2015 May 21.

12.

N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).

Astor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson G, Lewis J, Lash JP, Van Lente F, Gassman J, Wang X, Bakris G, Appel LJ, Contreras G.

Circulation. 2008 Apr 1;117(13):1685-92. doi: 10.1161/CIRCULATIONAHA.107.724187. Epub 2008 Mar 24.

13.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
14.

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.

Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J.

Clin Interv Aging. 2016 Feb 16;11:245-53. doi: 10.2147/CIA.S98151. eCollection 2016.

15.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.

Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2997-3003. doi: 10.1161/ATVBAHA.111.223669. Epub 2011 Sep 15.

16.

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.

Baggen VJ, van den Bosch AE, Eindhoven JA, Schut AW, Cuypers JA, Witsenburg M, de Waart M, van Schaik RH, Zijlstra F, Boersma E, Roos-Hesselink JW.

Circulation. 2017 Jan 17;135(3):264-279. doi: 10.1161/CIRCULATIONAHA.116.023255. Epub 2016 Nov 3.

17.

The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.

Mirza SS, de Bruijn RF, Koudstaal PJ, van den Meiracker AH, Franco OH, Hofman A, Tiemeier H, Ikram MA.

J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):356-62. doi: 10.1136/jnnp-2014-309968. Epub 2015 Apr 27.

PMID:
25918047
18.

The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Welsh P, Poulter NR, Chang CL, Sever PS, Sattar N; ASCOT Investigators.

Hypertension. 2014 Mar;63(3):507-13. doi: 10.1161/HYPERTENSIONAHA.113.02204. Epub 2013 Dec 9.

19.
20.

Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.

Lorgis L, Zeller M, Dentan G, Sicard P, Buffet P, L'Huillier I, Beer JC, Vincent-Martin M, Makki H, Gambert P, Cottin Y; RICO Survey Working Group.

BMJ. 2009 May 6;338:b1605. doi: 10.1136/bmj.b1605.

Supplemental Content

Support Center